PACS Group (NYSE:PACS) Stock: Insider Jason Hulse Murray Sells 19,235 Shares

PACS Group, Inc. (NYSE:PACS) CEO Jason Murray sold 19,235 shares of PACS Group stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $50.64, for a total transaction of $974,060.40. Following the sale, the chief executive officer owned 53,934,866 shares in the company, valued at approximately $2,731,261,614.24. This trade represents a 0.04% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Wednesday, November 4th, Jason Murray sold 167,434 shares of PACS Group stock. The shares were sold at an average price of $50.24, for a total transaction of $8,411,884.16.
• On Tuesday, November 3rd, Jason Murray sold 26,504 shares of PACS Group stock. The stock was sold at an average price of $46.50, for a total transaction of $1,232,436.00.
• On Monday, November 2nd, Jason Murray sold 31,358 shares of PACS Group stock. The stock was sold at an average price of $46.02, for a total transaction of $1,443,095.16.
• On Thursday, October 29th, Jason Murray sold 1,904 shares of PACS Group stock. The stock was sold at an average price of $50.05, for a total transaction of $95,295.20.
• On Wednesday, October 28th, Jason Murray sold 6,899 shares of PACS Group stock. The stock was sold at an average price of $50.10, for a total transaction of $345,639.90.
• On Friday, October 23rd, Jason Murray sold 68,917 shares of PACS Group stock. The shares were sold at an average price of $48.60, for a total value of $3,349,366.20.
• On Thursday, October 22nd, Jason Murray sold 13,696 shares of PACS Group stock. The shares were sold at an average price of $47.55, for a total value of $651,244.80.
• On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The shares were sold at an average price of $47.62, for a total value of $314,768.20.
• On Tuesday, October 20th, Jason Murray sold 37,477 shares of PACS Group stock. The shares were sold at an average price of $47.65, for a total value of $1,785,779.05.
• On Monday, October 19th, Jason Murray sold 1,620 shares of PACS Group stock. The stock was sold at an average price of $47.57, for a total transaction of $77,063.40.

PACS Group Price Performance

Shares of NYSE PACS traded down $1.03 during mid-day trading on Monday, hitting $48.57. 987,877 shares of the stock were exchanged, compared to its average volume of 899,428. The company has a market cap of $7.71 billion, a P/E ratio of 27.44, a PEG ratio of 1.55 and a beta of -0.14. The stock’s fifty day simple moving average is $44.64 and its two-hundred day simple moving average is $40.03. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.80 and a current ratio of 0.80. PACS Group, Inc. has a twelve month low of $10.31 and a twelve month high of $51.68.

PACS Group (NYSE:PACS) last released its quarterly earnings results on Tuesday, November 3rd. The company reported $0.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.58 by $0.05. PACS Group had a return on equity of 31.98% and a net margin of 4.87%. The business had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.46 billion. As a group, analysts forecast that PACS Group, Inc. will post 2.13 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on PACS shares. Stephens boosted their price objective on shares of PACS Group from $60.00 to $64.00 and gave the stock an “overweight” rating in a research report on Thursday. UBS Group increased their price objective on PACS Group from $60.00 to $67.00 and gave the company a “buy” rating in a research report on Thursday. Zacks Research cut PACS Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 9th. JPMorgan Chase & Co. boosted their target price on PACS Group from $47.00 to $58.00 and gave the stock an “overweight” rating in a research report on Friday, September 4th. Finally, Royal Bank Of Canada upped their price target on PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a research note on Thursday, August 6th. Seven research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, PACS Group presently has an average rating of “Moderate Buy” and an average target price of $61.33.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Eurizon Capital SGR S.p.A. acquired a new position in PACS Group in the third quarter valued at about $34,000. Fulcrum Asset Management LLP grew its position in shares of PACS Group by 244.8% during the 3rd quarter. Fulcrum Asset Management LLP now owns 11,014 shares of the company’s stock worth $465,000 after buying an additional 7,820 shares during the period. Vise Technologies Inc. grew its position in shares of PACS Group by 40.6% during the 3rd quarter. Vise Technologies Inc. now owns 7,209 shares of the company’s stock worth $300,000 after buying an additional 2,081 shares during the period. State of Wyoming grew its position in shares of PACS Group by 11.9% during the 3rd quarter. State of Wyoming now owns 10,551 shares of the company’s stock worth $438,000 after buying an additional 1,119 shares during the period. Finally, Smith Group Asset Management LLC increased its stake in shares of PACS Group by 1.3% in the 3rd quarter. Smith Group Asset Management LLC now owns 24,680 shares of the company’s stock valued at $1,025,000 after acquiring an additional 320 shares during the last quarter.

PACS Group Company Profile

PACS Group, Inc is a post-acute healthcare provider that operates skilled nursing and rehabilitation facilities. Its services include nursing care, physical and occupational therapy, and support for patients recovering from illness or injury, as well as care for people with ongoing or long-term needs.

Founded in 2013, the company has expanded its network of facilities across the United States. Its operations are organized through affiliated entities, with care and services tailored to the needs of residents and patients in the communities it serves.

PACS Group is led by co-founder and Chief Executive Officer Jason Murray.